Malignant Mesothelioma, BAP1 Immunohistochemistry, and VEGFA: Does BAP1 Have Potential for Early Diagnosis and Assessment of Prognosis?

Table 1

Patient information.

	Count (%)
Age, y, median (range)	74 (35–94)
Sex
Male	63 (78)
Female	18 (22)
Type
Pleural	80 (99)
Peritoneal	1 (1)
Subtype
Epithelioid	57 (70)
Biphasic	13 (16)
Sarcomatoid	11 (14)
Treatment
Surgery	2 (2)
Chemotherapy	23 (28)
Radiotherapy	9 (11)
BAP1 score (surgical)
<50%	47 (58)
≥50%	34 (42)
BAP1 score (cytology)
<50%	34 (60)
≥50%	23 (40)

Extrapleural pneumonectomy: EPP.